Neferine attenuates development of testosterone-induced benign prostatic hyperplasia in mice by regulating androgen and TGF-β/Smad signaling pathways

• Main Authors: Chi-Ming Liu (Author), ZiChen Shao (Author), XuZhou Chen (Author), HanWu Chen (Author), MengQiao Su (Author), ZiWen Zhang (Author), ZhengPing Wu (Author), Peng Zhang (Author), LiJie An (Author), YinJie Jiang (Author), Ai-Jun Ouyang (Author)
• Format: Book
• Published: Elsevier, 2023-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Benign prostatic hyperplasia (BPH) is a common urinary disease among the elderly, characterized by abnormal prostatic cell proliferation. Neferine is a dibenzyl isoquinoline alkaloid extracted from Nelumbo nucifera and has antioxidant, anti-inflammatory and anti-prostate cancer effects. The benefici...